Table 4.
Pharmacokinetic parameters of the active moiety (unbound tolterodine+the 5-hydroxymethyl metabolite) following treatment with tolterodine [as l-tartrate salt] 2 mg twice daily for 2.5 days in the absence and presence of fluoxetine (20 mg once daily for 27 days).